|
End-of-day quote
Shenzhen S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 63.17 CNY | -1.33% |
|
-4.66% | +5.87% |
| Market Cap | 5.05B 753M 669M 625M 570M 1.07B 72.48B 1.09B 7.56B 2.93B 36.91B 2.83B 2.77B 119B | P/E 2024 |
-22.7x | P/E 2025 | -46.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.38B 802M 712M 666M 607M 1.14B 77.17B 1.16B 8.05B 3.12B 39.3B 3.01B 2.94B 126B | EV / Sales 2024 |
6.46x | EV / Sales 2025 | 32.7x |
| Free-Float |
29.49% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.33% | ||
| 1 week | -4.66% | ||
| 1 month | +8.88% | ||
| 3 months | +5.71% | ||
| 6 months | +0.45% | ||
| Current year | +5.87% |
| 1 week | 63 |  | 66.83 |
| 1 month | 55.13 | | 69.74 |
| Current year | 44.55 | | 98.29 |
| 1 year | 40.91 | | 98.29 |
| 3 years | 12.6 | | 98.29 |
| 5 years | 12.6 | | 98.29 |
| 10 years | 12.6 | | 98.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Deng
CEO | Chief Executive Officer | 60 | 2018-11-30 |
Chao Li
DFI | Director of Finance/CFO | 47 | 2017-04-30 |
Fen Jin
DFI | Director of Finance/CFO | 46 | 2017-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Yong Deng
CHM | Chairman | 60 | 2017-11-30 |
Shao Zhong Zhang
BRD | Director/Board Member | 70 | 2020-02-20 |
Qin Deng
BRD | Director/Board Member | 58 | 2020-02-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.33% | -4.66% | +57.61% | +127.97% | 753M | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,031B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 638B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 462B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 359B | |
| -0.03% | -3.96% | +23.63% | +39.35% | 335B | |
| -1.58% | -0.76% | +13.50% | +25.77% | 273B | |
| -2.02% | -2.97% | -3.25% | +8.38% | 253B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 228B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 185B | |
| Average | -1.40% | -1.87% | +30.49% | +64.40% | 376.46B | |
| Weighted average by Cap. | -1.25% | -1.89% | +30.52% | +69.19% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 241M 35.85M 31.84M 29.77M 27.13M 51.08M 3.45B 51.78M 360M 139M 1.76B 135M 132M 5.65B | 154M 22.97M 20.4M 19.08M 17.38M 32.73M 2.21B 33.18M 231M 89.34M 1.13B 86.23M 84.36M 3.62B |
| Net income | -62.67M -9.34M -8.29M -7.75M -7.07M -13.3M -899M -13.49M -93.81M -36.31M -458M -35.05M -34.29M -1.47B | -102M -15.22M -13.52M -12.64M -11.52M -21.69M -1.47B -21.99M -153M -59.2M -746M -57.14M -55.91M -2.4B |
| Net Debt | 135M 20.06M 17.82M 16.67M 15.19M 28.59M 1.93B 28.98M 202M 78.05M 984M 75.33M 73.7M 3.16B | 327M 48.67M 43.23M 40.43M 36.84M 69.36M 4.69B 70.31M 489M 189M 2.39B 183M 179M 7.67B |
Employees
461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | CN¥63.17 | -1.33% | 609,200 |
| 26-09-29 | CN¥64.02 | +0.28% | 679,200 |
| 26-09-28 | CN¥63.84 | -3.65% | 897,600 |
| 26-09-24 | CN¥66.26 | +0.12% | 1,114,800 |
| 26-09-23 | CN¥66.18 | -1.61% | 937,800 |
- Stock Market
- Stocks
- 301075 Stock
Select your edition
All financial news and data tailored to specific country editions
